Close
Smartlab Europe
Inizio Ignite

News

Ascelia Pharma presents study showing comparable efficacy of Orviglance lesion visualization and detection to Gadolinium

Ascelia Pharma AB is presenting a study in which Orviglance® (manganese chloride tetrahydrate, former working name Mangoral) was compared against a gadolinium-based contrast agent at one of the world’s largest radiology conference, RSNA, in Chicago, Illinois. Orviglance is a novel...

Pistoia Alliance predicts a focus on the fight against antimicrobial resistance and a surge in quantum computing research for 2022

The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has today outlined predictions for the life sciences industry in 2022. The predictions come from three experts recently appointed by the Alliance to...

FedEx Express Named Asia’s Best Third-Party Logistics for Vaccine at the Asia Pacific Vaccine Excellence Awards 2021

FedEx Express (FedEx), a subsidiary of FedEx Corp. and one of the world’s largest express transportation companies, has been named “Asia’s Best 3PLs for Vaccines” at the Asia Pacific Vaccine Excellence Awards 2021 (AVEA 2021). FedEx was selected as “Asia’s...

McSAF and Novasep announce their successful collaboration to produce a next-generation Antibody-Drug Conjugate

Novasep, a leading supplier of services and technologies for the life sciences industry, and McSAF, a French biotech based in Tours, specialized in bioconjugation tools to design innovative and efficient bio drugs for health and diagnostics, are pleased to...

Sanofi invests $180 million equity in Owkin’s artificial intelligence and federated learning to advance oncology pipeline

Sanofi announced an equity investment of $180 million and a new strategic collaboration with Owkin comprised of discovery and development programmes in four exclusive types of cancer, with a total payment of $90 million for three years plus additional...

New Zealand approves India-made vaccines, Covishield and Covaxin

New Zealand has finally approved India-made vaccines, Covishield and Covaxin. The decision comes soon after Australia, New Zealand’s neighbour, recognised the two Indian vaccines last month. This means that Indian travellers vaccinated with these vaccines will not have to...

GSK and Vir Biotechnology announce United States government agreements to purchase sotrovimab, a COVID-19 treatment

GlaxoSmithKline plc and Vir Biotechnology, Inc. announced US government contracts totalling approximately $1 billion (USD) to purchase sotrovimab, an investigational monoclonal antibody for the early treatment of COVID-19, which the US Food and Drug Administration (FDA) granted Emergency Use...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »